# Trillium Therapeutics

**Canonical:** https://apis.io/providers/trillium-therapeutics/  
**Website:** https://www.trilliumtherapeutics.com  
**APIs profiled:** 0

Trillium Therapeutics was a Toronto-based clinical-stage immuno-oncology biopharmaceutical company developing cancer therapeutics (notably CD47-targeting agents). It was acquired by Pfizer in August 2021 for approximately $2.2B and no longer operates as an independent entity. Surfaced as an nea portfolio company and added to the API Evangelist network as a life-sciences lead. Enrichment found no public developer API, SDK, documentation, or developer-portal surface; the company website no longer serves content.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Life Sciences, Biopharmaceutical, Oncology, Immuno-Oncology, Cancer Therapeutics, Acquired

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/trillium-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.